BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7564505)

  • 21. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
    Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
    Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
    Towatari M; Ito Y; Morishita Y; Tanimoto M; Kawashima K; Morishima Y; Andoh T; Saito H
    Cancer Res; 1990 Nov; 50(22):7198-202. PubMed ID: 1699657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topoisomerase II levels during granulocytic maturation in vitro and in vivo.
    Kaufmann SH; McLaughlin SJ; Kastan MB; Liu LF; Karp JE; Burke PJ
    Cancer Res; 1991 Jul; 51(13):3534-43. PubMed ID: 1647269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
    Lodge AJ; Hall AG; Reid MM; McIntosh GG; Steward M; Anderson JJ; Horne CH; Angus B
    J Clin Pathol; 2001 Jan; 54(1):31-6. PubMed ID: 11271785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP; Brown GA; Goldenberg GJ
    Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
    Chikamori K; Hill JE; Grabowski DR; Zarkhin E; Grozav AG; Vaziri SA; Wang J; Gudkov AV; Rybicki LR; Bukowski RM; Yen A; Tanimoto M; Ganapathi MK; Ganapathi R
    Leukemia; 2006 Oct; 20(10):1809-18. PubMed ID: 16932348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
    Mo YY; Beck WT
    Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
    Chen G; Templeton D; Suttle DP; Stacey DW
    Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topoisomerase II alpha expression in acute myeloid leukaemia and its relationship to clinical outcome.
    McKenna SL; West RR; Whittaker JA; Padua RA; Holmes JA
    Leukemia; 1994 Sep; 8(9):1498-502. PubMed ID: 8090029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
    Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG
    Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
    Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
    Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
    Den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
    Leukemia; 1999 Dec; 13(12):2023-30. PubMed ID: 10602424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia.
    Guérin E; Entz-Werlé N; Eyer D; Pencreac'h E; Schneider A; Falkenrodt A; Uettwiller F; Babin A; Voegeli AC; Lessard M; Gaub MP; Lutz P; Oudet P
    Leukemia; 2003 Mar; 17(3):532-40. PubMed ID: 12646941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.